Epidemiologiya i patogeneticheskie faktory sindroma diabeticheskoy stopy u bol'nykh s terminal'noy stadiey khronicheskoy pochechnoy nedostatochnosti, nakhodyashchikhsya na dialize
https://doi.org/10.14341/2072-0351-5991
Abstract
Диабетическая нефропатия (ДН) - одно из серьезных осложнений длительно некомпенсированного сахарного диабета (СД). Терминальная стадия хронической почечной недостаточности (ТХПН) как исход ДН занимает первое место среди причин смертности больных СД 1 и уступает лишь сердечно- сосудистым и онкологическим заболеваниям у больных СД 2. Исследования, изучающие ТрГ как фактор риска нейро-ишемической формы СДС, отсутствуют. Тем не менее, анализируя данные литературы, можно предполагать, что ТрГ усугубляет ишемию нижних конечностей и провоцирует развитие нейро-ишемических язв и некрозов нижних конечностей у пациентов с СД, находящихся на диализе.
About the Authors
Evgenia V. Bublik
Endocrinology Research Centre, Moscow
Gagik R. Galstyan
ФПНПК ММА им. И.М. Сеченова, Москва
References
1. Шестакова М.В. Ведение больных сахарным диабетом с терминальной хронической почечной недостаточностью на диализе. // Методические указания. - 2004. - №38.
2. Бибков Б.Т. Анализ выживаемости и факторы риска неблагоприятных исходов у больных на программном гемодиализе: автореф. дисс. на соискание ученой степени канд. мед. наук. - М., 2004.
3. Moeller S., Gioberge S., Brown G. ESRD patients in 2001: global overview of patients, treatment modalities and developing trends. // Nephrol. Dial.Transplant. - 2002. - Vol.17. - P. 2071-2076.
4. Андрусев А.М. Перитонеальный диализ: отдаленные результаты лечения, факторы, их определяющие и клиническая патофизиология метода. Нефрология и диализ. - 2005. - Т.7. -№2. - C. 34.
5. Davies S.J., Phillis L., Griffiths A.M. et al. What really happens to people on long-term peritoneal dialysis? // Kidney Int. -1998. - Vol.54. P.2207-2217.
6. Cueto-Manzano A.M., Quintana-Pina E., Correa-Rotter R. Long-term CAPD survival and analysis of mortality risk factors: 12-years experience of a single Mexican center. // Perit. Dial. Int. -2001. - Vol.21. - P. 148-153.
7. Held P.J., Port F.K., Turenne M.N., Gaylin D.S. et al. Continuous ambulatory peritoneal dialysis and haemodialysis: comparison of patient mortality with adjustment for comorbid conditions. // Kidney Int. - 1994. - Apr; 45(4). - P. 1163-1169.
8. U S Renal Data System: USRDS 2001, Annual Data Report. Betheasda, MD, National Institute of Health, National Institute of Diabetes and digestive and Kidney Disease. 2003.
9. U.S. Renal Data System, USRDS 2003. // Annual Data Report: Atlas of End - Stage Renal Disease in the United States. -2003. - P. 560.
10. The International Working Group on the Diabetic Foot. International consensus and practical guidelines on the management and the prevention of the diabetic foot -1999.
11. Edwards J.M., Taylor L.M., Porter J.M. Limb salvage in end-stage renal disease (ESRD). Arch. Surg. - 1988. - Vol.123. - P. 1164-1168.
12. Morbach S., Quante C., Ochs H.R., Gaschler F. Increased Risk of Low - Extremity Amputation Among Caucasian Diabetic Patients on Dialysis. // Diabetes Care. - 2001. - Vol.24. - P. 1689-1690.
13. Schomig M., Standl E. Diabetic foot in the Dialyzed Patients. // Am. Soc. Of Nephrology-2000. - Vol.11. - P.1153-1159.
14. Game F.L., Chipchase S.Y., Burden R.P., Jeffcoat W.J. Close temporal association between established renal failure and the incidence of both ulcers and major amputations in diabetes mellitus. // Diabetic Foot Study Group of the EASD 2005. -O27. - P.44.
15. Frykberg R., Pedhe C., Pearson D., Beecroft J. // The prevalence of foot problems in patients with diabetes undergoing haemodialysis. // Abstractbook of the 2nd Meeting of the DFSG (Crieff, UK, 7-9 Sept, 2001), p.11.
16. Frykberg R., Sauter T., Broadbent B., Sudberry A. et al. IOWA. United States. The prevalence of Foot Problems in Patients with Diabetes Undergoing Haemodialysis. // Joint meeting of the NEURODIAB and DFSG. - 2002. - A19.
17. Дедов И.И., Галстян Г.Р., Токмакова А.Ю., Удовиченко О.В. Синдром диабетической стопы. / Пособие для врачей. 2003. - C. 9-11.
18. Lavery A.L., Ashry H.R., van Houtum W., Pugh J.A., Harkless L.B., Basu S. Variation in the Incidence and Proportion of Diabetes-Related Amputations. // Diabetes care. - 1996. - Vol. 19,N 1. - P. 48-51.
19. O'Hara A.M., Bacchetti P., Segal M., Hsu C.Y., Johansen K.L. Factors associated with future amputation among patients undergoing haemodialysis: results from the Dialysis Morbidity and Mortality Study Waves 3 and 4. // Am. J. Kidney Dis. - 2003. - Jan; 41(1). - P. 162-70.
20. McGrath N.M., Curran B.A. Recent commencement of dialysis is a risk factor for low-extremity amputation in a high-risk diabetic population. // Diabetic Care.-2000. - Vol.23. - P. 432-433.
21. Rith-Najarian S., Gohdes D. Preventing amputations among patients with diabetes on dialysis. // Diabetes Care.-2000. - Vol.23. - P.1446.
22. Moss S.E., Klein R., Klein B.E. Long-term incidence of low-extremity amputations in diabetic population. // Arch. Fam. Med.-1996. - P.391 -3898.
23. Eggers P.W., Gohdes D., Pugh J. Nontraumatic lower extremity amputations in the Medicare end-stage renal disease population. // Kidney Int.- 1999. - 56:1524-1533.
24. Анцифиров М.Б., Токмакова А.Ю., Галстян Г.Р., Удовиченко О.В. «Синдром диабетической стопы» Атлас для врачей-эндокринологов. - 2002. - C.5.
25. Левин О.С. Полиневропатиии. // Клиническое руководство. - 2005. МИА. C.228-230.
26. Чупрасов В.Б. Программный гемодиализ // Практическое руководство для врачей.-2001.
27. Lindholm B., Lindholm B., Tegner R. et al. Progress of peripheral uremic neuropathy during continuous ambulatory peritoneal dialysis. // ASAIO Nrans. -1982. - Vol.28. - P.263.
28. Scribner B.H. Long term peritoneal dialysis. // Proct. EDTA-1975. - Vol.12. -P. 131-165.
29. Scribner B.H. Some thoughts on research to define the adequacy of dialysis. // Kidney Int.-1975. - Vol.7, suppl. 2. - P.3-5.
30. Babb A.L., Strand M.J., Uvelli D.A., Milutinovic J., Scribner B.H. Quantitative description of dialysis treatment: a dialysis index. // Kidney Int.-1975. - Vol.7.(Suppl.2). - P. 23-30.
31. Laaksonen S., Voipoi-Pulkki L., Erkinjuntti M. et al. Does dialysis therapy improve autonomic and peripheral nervous system abnormalities in chronic uremia? // J. Intern. Med. - 2000. - Jul;248(1). - p.21-26.
32. Bazzi C., Pagani C., Sorgato G., Albonico G. et al. Uremic polyneuropathy: a clinical and electrophysiological study in 135 shot- and long-term haemodialysis patients. // Clin. Nefrol. - 1991. - Vol.35 - P.176.
33. Albertazzi A., Capelli P., Maccarone M., Di Paolo B. The natural history of uremic neuropathy. // Contrib. Nephrol. 1988. - Vol.7 - P.130.
34. Европейские рекомендации по оптимальной практике гемодиализа. // Нефрология и диализ.-2005.- часть 1.
35. Ермоленко В.М., Яровая Е. В., Шутов Е.В., Грабская Е. С. Дислипидемия у больных с терминальной уремией на постоянном амбулаторном перитонеальном диализе. // Нефрология и диализ.- 2002. - Т4. - N2. - C.118-120.
36. Lima J.G., Vieira M.L., Abensur H., Krieger E.M. Baseline blood pressure and other variables influencing survival on haemodialysis of patients without overt cardiovascular disease. // Nephrol. Dial. Transplant. - 2001. - Vol.16. - P.793-797.
37. Foley R.N., Parfrey P.S., Sarnak M.J. Clinical epidemiology of cardiovascular disease in chronic renal disease. // Am. J. Kidney Dis.-1998. - Vol.32 [5 Suppl 3]. -P.112-119.
38. Перекокин Ю.Н., Шило В.Ю., Гендлин Г.Е., Денисов А.Ю., Сторожаков Г.Е. Скорость пульсовой волны и податливость аорты у больных на программном гемодиализе: связь с факторами риска, кальцинозом сердца и показателями внутрисердечной гемодинамики. // Нефрология и диализ.-2004. - N1. - C.62-69.
39. Шило В.Ю. Кальциноз сердца и сосудов у больных на программном гемодиализе: распространенность, механизмы кальцификации, связь с факторами риска, лечение и профилактика. // Материалы 6-й российско-французской школы-семинара «Передовые рубежи нефрологии»-2004. - C.113-12.
40. Кутырина И.М., Руденко Т.Е., Дзитоева М.Ю. Ремоделирование сосудов при хронической почечной недостаточности. // Клин. мед.- 2005. - N2. - C.16-22.
41. Misra M., Vonesh E., Stone J.C. et al. Effect of cause and time of dropout on the residual GFR: A comporatove analysis of the decline of GRF on dialysis. // Kidney Int.-2001. - Vol.59. - P.754-763.
42. Besarab A., Bolton K., Brown J.K. et al. The effects of normal as compared with low heamatocrit values in patients with cardiac disease who are receiving haemodialysis and erythropoietin. // N. Engl. J. Med .- 1998. - Vol.339.- P.584-590.
43. Hoeben H., Van Biesen W., Lamaire N. Cardiovascular problems in peritoneal dialysis patients: short overview. // Perit. Dial.-1999. - Vol.19 (Suppl.2). - P.150-158.
44. Милованова Л.Ю., Николаев А.Ю., Милованов Ю.С. Гиперфосфатемия как фактор риска сердечно-сосудистых заболеваний у больных ХПН на программном гемодиализе. // Нефрология и диализ. -2002 - 4, 2. - C.113-117.
45. Davies S.J. Assessment of comorbidity in peritoneal dialysis. // In. Ronco C. (eds). Contributions to nephrology.-2003; Peritoneal dialysis today. P.98-103. Karger.
46. Joki N. Hase H., Ishikawa H., Fukazawa C., Nakamura R. et al. et al. Coronary artery disease as a definitive risk factor of short-term of outcome after starting haemodialysis in diabetic renal failure patients. // Clin. Nephrol.-2001. - Feb;55(2). - P.109-14.
47. Prichard S. Cardiovascular risk in peritoneal dialysis. // In: Ronco C (eds). Contributins to nephrology // Peritoneal dialysis today. Karger. - 2003. - Vol.140. - P.82-90.
48. Nakamura S., Sasaki O., Nakamura H. et al. Clinical characteristics and survival in end-stage renal disease patient with arteriosclerosis obliterans. // Am. J Nephrol.-2002.- Vol.22 (5-6) - P.422-428.
49. Cooper B.A., Penne E.l., Bartlett L.H., Pollock C.A. Protein malnutration and hypoalbuminemia as predictors of vascular events and mortality in ESRD. // Am. J. Kidney Dis.-2004 - Jan; 43(1) - P.61-6.
50. Harnett J.D., Foley R.N., Parfrey P.S. Left ventricular dysfunction in dialysis subjects. // Principles and practice of dialysis (ed. 2).-1999. - P.235- 245.
51. Hong Kong Williams&Wilkins. Yasuhara H., Naka S., Yanagia H., Nagawa H. Influence of diabetes on persistent nonhealing foot ulcer in end-stage renal disease. // World J. Surg.-2002. - Nov;26(11). - P.1360-4.
52. Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In adults (Adult Treatment Panel III). // J. Am. Med. Assoc.-2001. - Vol.285. - P.2486-2497.
53. Cheung A.K., Wu L.L., Kablitz C., Leypoldt J.K. Aterogeniclipids and lipoproteins in haemodialysis patients. // Am. J. Kidney Dis.-1993. - Vol.22. - P.271-276.
54. Rostand R.G., Kirk K.A., Rutsky E.A. Dialysis ischemic heart disease: Insight from coronary angiography. // Kidney Int.-1984. - Vol.25. - P.653-59.
55. Malatino L.S. Benedeto H.A., Mallamaci H. et al. Smoking, blood pressure and serum albumin are major determinates of carotid atherosclerosis in dialysis patients. CREED Investigations. Cardiovascular Risk Extended Evaluation on Dialysis patients. // J. Nephrol.-1999. - Vol.12. - P.256-260.
56. Biesenbach G., Zazgornik J. Influence of smoking on the survival rate of diabetic patients requiring haemodialysis. // Diabetes Care.-1996. - Lol.19. - P.625-628.
57. Kawagishi T., Nishizawa Y., Konishi T. et al. High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia. // Diabetes Care. - 1995. - Vol.48. - P.820-826.
58. Sakurabayashi T., Hujimoto M., Takaesu Y. et al. Assosiation between plasma homocysteine concentration and carotid atherosclerosis in haemodialysis patients. // Jpn. Circ. J. -1999. - Vol.63. - P.692-696.
59. Amann K., Gross M.L., London G.M. et al. Hyperphosphataemia - a silent killer of patients with renal failure? // Nephrol. Dial. Transplant. - 1999. - Vol.14 - P.2085-2087.
60. Block G.A., Hulbert-Shearon T.E., Levin N.W., Port F.K. Association of serum phosphorus and calciumЧphosphate product with mortality risk in chronic heamodialysis patients: a national study. // Am. J. Kidney Dis.- 1998. - Vol.31. - P.601-617.
61. Jono S, Nishizawa Y, Shioi A, Morii H. 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. // Circulation. - 1998. - Vol.98. - P.1302-6.
62. Eckardt K.U. Cardiovascular consequences of renal anemia and erythropoietin therapy. // Nephrol. Dial. Transplant.-1999 - Vol.14(5). - P.1317-1323.
63. Amann K., Wiest G., Klaus G., Ritz E., Mall G. The role parathyroid hormone in the genesis of interstitial cell activation in uremia. // J. Am. Soc. Nephrol. 1994. - Vol.4. - P.1814-1819.
64. Bogin E., Massry S.G., Harary I. Effect of parathyroid hormone on heart cells. // J. Clin. Invest.-1981. - Vol.67. - P.1215-1227.
65. Fellner S.K., Lang R.M., Neumann A. et al. Parathyroid hormone and myocardial performance in dialysis patients. // Am. J. Kidney Dis. - 1991. - Vol.18. - P.320-325.
66. Nishizawa Y., Sboji T., Kawagisbi T., Morii H. Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation. // Kidney Int.-1997. - Vol.52, (Suppl. 2). - P.90-92.
67. London G.M., Guerin A.P., Marchais S.J. et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. // Nephrol. Dial. Transplant. 2003. - Vol.18 (9). - P.1731-1732.
68. Goodman W.G., Goldin J., Kuizon B.D., Yoon C., Gales B. et al. Coronary-artery calcification in young adults with end stage renal disease who are undergoing dialysis. // N. Engl. J. Med. - 2000. - Vol.342. - P.1478-1483.
69. Becker B.N., Himmelfarb J., Heinrich W.L., Hakim R.M. Re-assesing the cardiac risk profile in chronic haemodialysis patients: a hypothesis on the role of oxidative stress and other non-traditional risk factors. // J. Am. Soc. Nephrol.-1997. - Vol.8. - P.475-486.
70. Kielstein J. T., Boger R.H., Bode-Boger S.M. et al. Asymmetric dimethylarginine plasma concentration differ in patients with end-stage renal disease: relationship to treatment method and atherosclerotic disease. // J Am. Soc. Nephrol. - 1999. - Vol.10. - P.594-600.
71. Zoccali C., Benedetto F.A., Maas R. et al. Asymmetric dimethylargenin (ADMA): and endogenous inhibitor of NO synthesis is elated to the severity of atherosclerosis and predicts mortality in end-stage renal disease (ESRD). // J. Am. Soc. Nephrol.-2000. - Vol.11. - P.308.
72. Daugirdas J., Blake P.G., Todd S. Handbook of Dialysis. // Lippincott Williams&Wilkins.-2003.
73. Дзитоева М.Ю. Ранняя диагностика и оценка распространенности кальциноза/атеросклероза у больных хронической почечной недостаточностью. // Диссертация на соискание ученой степени кандидата медицинских наук. 2006.
74. Roig E., Betriu A., Castaner A. et al. Disabling angina pectoris with normal coronary arteries in patients undergoing haemodialysis. // Am. J. Med. -1981. - Vol.71. - P.437-44.
75. Blacher J., Guerin A.P., Pannier B., Marchais S.J., London G.M. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. // Hypertension.-2001. - Vol.38. - P.938-942.
76. Kuzela D.C., Huffer W.E., Conger J.D. et al. Soft tissue calcification in chronic dialysis patients. // Am. J. Pathol. - 1977. - Vol.86. - P.403-24.
77. Riley W.A., Evans G.W., Sharrett A.R., Burke G.L., Barnes R.W. Variation of common carotid artery elasticity with intimal-medial thickness: the ARIC study: Atherosclerosis Risk in Communities. // Ultrasound Med. Biol.-1997. - Vol.23. - P.157-164.
78. Nitta K., Akiba T., Uchida K. et al. The progression of vascular calcification and serum osteoprotegerin levels in patients on long-term haemodialysis. // Am. J. Kidney Dis.-2003. - Vol.42. - P. 303-309.
79. Moe S.M., O'Neill K.D., Duan D. et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins. // Kidney Int.-2002.- Vol.61. - P.638-647.
80. Guerin A.P., London G.M., Marchais S.J., Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. // Nephrol. Dial. Transplant. - 2000. - Vol.15. - P.1014-1021.
81. Guerin A.P., London G.M., Marchais S.J., Metivier F. Arterial coronary heart disease with age-adjusted aortocoronary calсiffening and vascular calcifications in end-stage renal disease in patients with familial hypercholesterolemia. // J. Nephrol. Dial. Transplant. - 2000. - Vol.15. - P.1014-1021.
82. Monckeberg J.G. Uber die reine Mediaverkalkung der Extremitatenarterien und ihr Verhalten zur Arteriosklerose. // Virchows Arch. (Pathol Anat).-1903.- Vol.171. - P.141-167.
83. Doherty T.M., Fitzpatrick L.A., Inoue D., Qiao J. et al. Molecular, Endocrine, and Genetic Mechanisms of Arterial Calcification. // Endocrine Reviews.-2004.-Vol.25(4). - P.629-672.
84. London G.M., Guerin A.P., Marcbais S.J. et al. Cardiac and arterial interactions in end-stage renal disease. // Kidney Int.-1996. - Vol.50. - P. 600-608.
85. Ahmed S., O'Neill K.D., Hood A.F., Evan A.P. et al. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. // Am. J. Kidney Dis.- 2001. - Vol.37. - P.1267-1276.
86. Giachelli C.M., Jono S., Shioni A.. et al. Vascular calcification and inorganic phosphate. // Am. J. Kidney. Dis. - 2001. - Vol.38. - P.S34-37.
87. Gafter U., Battler A., Eldar M., Zevin D., Neufeld H.N., Levi J. Effect of hyperparathyroidism on cardiac function in patients with end-stage renal disease. // Nephron.-1981. - Vol. 41. - P.30-33.
88. Hino T., Hyby N.D., Fittingoff M., Tuck M.L., Brickman A.S. Parathyroid hormone analogues inhibit calcium mobilization in cultured vascular cells. // Hypertension. - 1994. - Vol.23. - P.402-408.
89. Hanson A.S., Linas S.L. Parathyroid hormone/adenylate cyclase coupling in vascular smooth muscle cells. Hypertension. - 1994. - Vol.23. - P.468-475.
90. Jono S., McKee M.D., Murry C. et al. Phosphate regulation of vascular smooth muscle cell calcification. // Circ. Res. - 2000. - Vol.87. - P.10-17.
91. Komelyagina E.U., Andrusev A.M. «The evaluation of risk profile for foot ulceration in patients undergoing peritoneal dialysis» 4th international Symposium on the diabetic foot. 2003. - P.33.
92. Misra M., Vonesh E., Stone J.C. et al. Effect of cause and time of dropout on the residual GFR: A compоratove analysis of the decline of GRF on dialysis. // Kidney Int.-2001. - Vol.59. - P.754-763.
93. Luo G., Ducy P., McKee MD et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. // Nature 1997. - Vol.386. - P.78-81.
94. Nitta K., Ishizuka T., Horita S., et al: Soluble osteopontin and vascular calcification in heamodialysis patients. // Nephron.-2001. - Vol.89. - P.455-458.
95. Stenvinkel P., Ketteler M., Johnson R.J., Lindholm B. IL-10, IL-6 and TNFalpha: central factors in the altered cytokine network of uremia. // Kidney Int.-2005. - Vol.67. - P.1216-1233.
96. Ketteler M., Bongartz P., Westenfeld R. et al. Association of low fetuin-A (AHSG) concentrations in serum with cardio-vascular mortality in patients on dialysis: a cross-sectional study. // Lancet. - 2003. - Vol.361. - P.827-33.
97. Moe S.M., Duan D., Duehle B.P., O'Neill K.D., Chen N.X. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. // Kidney Int.-2003.-Vol.63. - P.1003-11.
98. Moe S.M., O'Neil K.D., Duan D., Chen N.X. Uremia induces Cbfa1 expression in vivo and in vitro in vascular smooth muscle cells. // Kidney Int.-2003. - Vol.63. - - P.1003-1011.
99. Psyrogiannis A., Kyriazopoulou V., Vagenakis A.G. Medial arterial calcification is frequently found in patients with microalbuminuria. // Angiology 1999. - Vol.50. - P.971-975.
100. Yamagishi S., Fujimori H., Yonecura H. et al. Advanced glycation endproducts accelerate calcification in microvascular pericytes. // Biochem. Biophys. Res. Commun.-1999. - Vol.258. - P.353-357.
101. Bowen B., Koenig E.C., Viele A. A study of the lower extremities in diabetes as compared with nondiabetic states from the standpoint of x-ray findings with particular reference to the relationship of arteriosclerosis and diabetes. // Bulletin Buffalo General Hospital.-1924. - Vol.2 - P.35-41.
102. Chantelau E., Lee K.M., Jungblut R. Distal arterial occlusive disease in diabetes is related to medial arterial calcification. // Exp. Clin. Endocrinol. Diabetes.-1997 105(Suppl 2)- P.11-13.
103. Morrison L., Bogan I.K. Calcification of the vessels in diabetes. // JAMA -1929. - Vol.92. - P.1424-1426.
104. Lindbom A. Arteriosclerosis and arterial thrombosis in the lower limb. A roentgenological study. // Acta. R. Radiol. (Diagn). - 1950. - Vol.80. - P.38-48.
105. Seshanarayana K.N., Keats T.E. Intrarenal arterial calcification: roentgen appearance and significance. // Radiology. 1970. - Vol.95. - P.145-147.
106. Fuchs U., Caffier P., Schulz H.G., Wieniecki P. Arterial calcification in diabetics. // Virchows Arch. A. Pathol. Anat. Histopathol.-1985.- Vol.407. P.431-439.
107. Niskanen L., Siitonen O., Suhonen M. et al. Medial artery calcification predicts cardiovascular mortality in patients with NIDDM. // Diabetes Care.-1994. - Vol.17. - P.1252-1256.
108. Gilbey S.G., Walters H., Edmonds M.E., Archer A.G. et al. 1989 Vascular calcification, autonomic neuropathy, and peripheral blood flow in patients with diabetic nephropathy. // Diabet. Med. - 1989. - Vol.6. - P.37-42.
109. Gentile S., Bizzarro A., Marmo R. et al. Medial arterial calcification and diabetic neuropathy. // Acta. Diabetol. Lat.-1990. - Vol.27. - P.243-253.
110. Young M.J., Adams J.E., Anderson G.F. et al. Medial arterial calcification in the feet of diabetic patients and matched non-diabetic control subjects. // Diabetologia.-1993. - Vol.36. - P.615-621.
111. Lehto S., Niskanen L., Suhonen M. et al. Medial artery calcification. Aneglected harbinger of cardiovascular complications in non-insulindependent diabetes mellitus. // Arterioscler. Thromb. Vasc. Biol. - 1996. - Vol.16: - P.978-983.
112. Edmonds M.E. Medial arterial calcification and diabetes mellitus. // Z Kardiol.-2000.- Vol.89(Suppl 2). - P.101-104.
113. Edmonds M.E., Morrison N., Laws J.W., Watkins P.J. Medial arterial calcification and diabetic neuropathy. // Br. Med. J. (Clin Res Ed)- 1982. - Vol.284 - P.928-930.
114. Watkins P.J., Edmonds M.E. Sympathetic nerve failure in diabetes. // Diabetologia.-1983. - Vol.25. - P.73-77.
115. Forst T., Pfutzner A., Kann P., Lobmann R. et al. Association between diabetic-autonomic-C-fibre-neuropathy and medial wall calcification and the significance in the outcome of trophic foot lesions. // Exp. Clin. Endocrinol. Diabetes.-1995.-Vol.103. - P.94-98.
116. Goebel F.D., Fuessl H.S. Monckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. // Diabetologia.- 1983.- Vol.24. - P.347-350.
117. Kitagawa S., Yamaguchi Y., Kunitomo M., Imaizumi N., Fujiwara M. Impairment of endothelium-dependent relaxation in aorta from rats with arteriosclerosis induced by excess vitamin D and a high-cholesterol diet. // Jpn. J. Pharmacol. - 1992. - Vol.59. - P.339-347.
118. Anderson H.C. Molecular biology of matrix vesicles. // Clin. Orthop.- 1995. - Vol. 80. - P.314:266.
119. Henschel A., Dannenberg L., Gobel U., Ott A., Schultz-Ehrenburg U. Disseminated ischemic necrosis and livedo racemosa in a chronic dialysis patients with calciphylaxis. // Hautarzt. - 1999.- Jun;50(6). - P.439-444.
120. an Popele N.M., Grobbee D.E., Bots M.L., Asmar R. et al. Association between arterial stiffness and atherosclerosis: the Rotterdam study. // Stroke.-2001. - Vol.32. - P.451-460.
121. Shanahan C.M., Cary N.R., Metcalfe J.C., Weisberg P.L. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. // J. Clin. Invest.-1994. - Vol.93. - P.2393-402.
122. Suzuki E., Kashiwagi A., Nishio Y., et al.: Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. // Diabetes Care. -2001. - Vol.24. - P.2107-2114.
123. McGill J.B., Bell D.S. Anemia and the role of erythropoietin in diabetes. // J. Diabetes Complications.-2006. - Jul-Aug;20(4) - P.262-72.
124. Panichi V., Casarosa I., Gattai V. et al. Protein layer on haemodialysis membranes: a new immunohistochemistry technique. // Int. J. Artif. Organs.-1995. - Vol.18. - P.305-308.
125. Cases A., Reverter J.C., Escolar G. et al. In vivo evaluation of platelet activation by different cellulosic membranes. // Artif. Organs.-1997. Vol.21. - P.330-334.
126. Warkentin T.E., Chong B.H., Greinacher A. Heparin-induced thrombocytopenia: towards consensus. // Thromb. Haemost.-1998. - Vol.79. - P.1-7.
127. Sitter T., Spannagl M., Banas B. et al. Prevalence of heparin-induced PF4-heparin antibodies in haemodialysis patients. // Nephron.-1998. - Vol.79. - P.245-246.
128. Leblanc M., Roy L.F., Legault L. et al. Severe skin necrosis associated with heparin in haemodialysis. // Nephrol. - 1994. - Vol.68. - P.133-137.
129. Carrozza P., Gabutti L., Gilliet F., Marone C. Heparin-induced systemic inflammatory response syndrome with progressive skin necrosis in haemodialysis. // Nephrol. Dial. Transplant.- 1997. - Vol.12. - P.2424-2427.
130. Fabrizi F., Sangiorgio R., Pontoriero G., Corti M. et al. Antiphospholipid (aPL) antibodies in end-stage renal disease. // J. Nephrol.-1999. - Mar-Apr;12(2). - P.89-94.
131. Brunet P., Aillaud M.F., San Marco M., Philip-Joet C. et al. Antiphospholipids in haemodialysis patients: relationship between lupus anticoagulant and thrombosis. // Kidney Int.-1995.- Sep;48(3). - P.794-800.
132. Weiss T., Windtorst C., Weiss C., Kreuzer J. et al. Acute effects of haemodialysis on cutaneous microcirculation in patients with peripheral arterial occlusive disease. // Nephrol. Dial. Transplant.-1998.- Sept;13(9). - P.2317-21.
133. Beker S., Sundermann K., Wolf S. et al. Haemodialysis impairs cutaneous microcirculation in diabetic patients. // VI. Meeting of DFSG. - 2006. - Q2. - P.19.
134. Daugirdas J.T., Ing T.S. Dialysis hypotension: a hemodinmic analysis. // Kidney Int.-1991. - Vol.39. - P.233.
135. Ornt D.B. Volumetric control of ultrafiltration reduces the rate of hypotention on heamodialysis. // J. Am. Soc. Nefrol.-1992 - Vol.3. - P.384.
136. Milovanova L.I., Nikolaev A.I., Safonov V.V. et al. Intradialysis hypotension: causes and sequelae. // Ter. Arkh.-2003. - Vol.75(6). - P.50-3.
137. Steuer R.R., Leypoldt J.K., Cheung A.K. et al. Reducing symptoms during haemodialysis by continuously monitoring the hematocrit. // Am. J. Kidney Dis.-1996. - Vol.27. - P.52.
138. Sang G.L., Kovithavongs C., Ulan R., Kjellstrand C.M. Sodium ramping in haemodialysis: a study of beneficial and adverse effects. // Am. J. Kidney Dis.-1997. - Vol.29. - P.669.
139. Keen M. Plasma sodium setpoint: Relationship to interdialytic weight gain and mean arterial pressure in haemodialysis patients. // J. Am. Soc. Nephrol. -1997. - Vol.8. - P.241A.
140. Cruz D.N., Mahnensmith R.L., Brickel H.M., Perazella M.A. Midodrine and cool dialysate are effective therapies for symptomatic intradialytic hypotension. // Am. J. Kidney Dis.-1999. - Vol.33 - P.920-926.
141. Barakat M.M. Haemodynamic effects of intradialytic food ingestion and the effects of caffeine. // J. Am. Soc. Nephrol.-1993. - Vol.3. - P.1813.
142. Lipidz L.A., Ryan S.M., Parker J.A., Freeman R. et al. Hemodinamic and autonomic nervous system responses to mixed meal ingestion in healthy young and old subjects and disautonomic patients with postprandial hypotension. // Circulation.-1993.-Feb;87(2). - P.391-400.
143. Shinzato T., Nakai S., Odani H., Nakane K., Takai I., Maeda K. Relationship between dialysis induced hypotension and adenosine released by ischemic tissue. ASAIO. 1992. - Vol.38. - P.286.
144. Calvo C., Maule S., Mecca F., Quadri R., Martina G., Cavallo Perin P. The influence of autonomic neuropathy on hypotension during haemodialysis. // Clin. Auton. Res.-2002.- Apr;12(2). - P.84-7.
145. Lee P.T., Fang H.C., Chen C.L., Chung H.M., Chiou Y.H., Chou K.J. High vibration perception threshold and autonomic dysfunction in haemodialysis hypotension. // Kidney Int. - 2003 - Sept;64(3). - P.1089-94.
146. Enzmann G., Bianco F., Paolini F., Panzetta G. Autonomic nervous function and blood volume monitoring during haemodialysis. // Int. J. Artif. Organs.-1995.-Sept;18(9) - P.504-508.
147. Chang M.N., Chou K.J. The role of autonomic neuropathy in the genesis of intradialytic hypotension. // Am. J. Nephrol.-2001. - Sept- Oct;21(5). - P.357-61.
148. Andras T., Tisler A., Akocsi K., Borbas B. et al. The Effect of Frequent and Occasional Dialysis Associated Hypotension on Survival of Patient on Maintenance Haemodialysis. // J. Am. Nephrol. - 2003. - Vol.14. - P.841A.
149. Saran R., Arbor A. Predialysis systolic BP below 110mm. Hg. predicts the highest risk of death on dialysis. // Renal & Urology News.-2005.- N3.
150. Dardik A., Moesinger R.C., Efron G., Barbul A., Harrison M.G. Acute abdomen with colonic necrosis induced by Kayexalate-sorbitol. // South. Med. J.-2000. - Lol.93. - P.511-513.
151. Iseki K, Fukiyama K; Clinical demographics and long-term prognosis after stroke in patients on chronic haemodialysis. // Okinawa Dialysis Study Group. // Nephrol. Dial. Transplant.-2000. - Vol.15. - P.1808-1813.
Review
For citations:
Bublik E.V., Galstyan G.R. Epidemiologiya i patogeneticheskie faktory sindroma diabeticheskoy stopy u bol'nykh s terminal'noy stadiey khronicheskoy pochechnoy nedostatochnosti, nakhodyashchikhsya na dialize. Diabetes mellitus. 2007;10(3):10-16. (In Russ.) https://doi.org/10.14341/2072-0351-5991
Views:
749
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
